跳至主要内容
临床试验/TCTR20200317007
TCTR20200317007尚未招募3 期

Efficacy of Melatonin Treatment of Nocturia : a randomized controlled study

Siriraj Routine to research fund0 个研究点目标入组 60 人开始时间: 2020年3月17日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
55 Years 至 100 Years(—)
性别
Female

入选标准

  • Patients who attend Urogynecology unit, Siriraj Hospital with
  • -Nocturia patients (>1 times per night)
  • -Age at least 55 years old
  • -Welcomed participants

排除标准

  • Patients with
  • Neurological or psychological abnormalities
  • History of drug allergy or side effects from melatonin
  • Hepatic or renal dysfunction
  • Uncontrolled diabetes mellitus, diabetes insipidus and cardiovascular disease
  • Currently taking diuretic, tranquillizer, hypnotics or melatonin
  • Urinary tract infection or tumor
  • Pelvic organ prolapse at least stage 3
  • Pelvic organ tumor
  • Urinary retention
  • Currently smoking
  • Taking medication that interact with pharmacokinetics of melatonin including carbamazepine, quinolone, rifampicin, cimetidine, estrogen

研究者

发起方
Siriraj Routine to research fund

相似试验

Efficacy of Melatonin Treatment of Nocturia : a... | 临床试验